title: EASL HCC summit: liver cancer management.
abstract: EASL HCC Summit, Geneva, Switzerland, 13-16 February 2014. The European Association for the Study of the Liver (EASL) organized the 2014 EASL HCC Summit in Geneva, Switzerland. We discuss here the most interesting and provocative contents from the clinical program of the summit. The objective of this segment was to provide an in-depth review on the different management issues related to early detection, diagnosis and treatment of hepatocellular carcinoma, and, in addition, to highlight the ways of dealing with such an important and rapidly involving field.
authors.affiliation: Dipartimento di Gastroenterologia-UO Gastroenterologia e Malattie del Ricambio, Azienda Ospedaliero Universitaria Pisana, Ospedale Cisanello Via Paradisa 2, 56124 Pisa, Italy.
authors.forename: Rodolfo
authors.initials: R
authors.lastname: Sacco
authors.forename: Gennaro
authors.initials: G
authors.lastname: Gadaleta-Caldarola
authors.forename: Giovanni
authors.initials: G
authors.lastname: Galati
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Lombardi
authors.forename: GianCarlo
authors.initials: G
authors.lastname: Mazza
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Cabibbo
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D055088:Early Detection of Cancer / Q000379:methods; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents
keywords: HCC; TACE; cost–effectivness; disease management; locoregional treatments; sorafenib